ReNeuroGen LLC

ReNeuroGen LLC is a biotech company in Elm Grove, United States, founded in 2018. It has raised $686K across 3 rounds, most recently a $100K Grant in December 2025.

Employees
1–10
Founded
2018
Business Model
B2B
Website
rngen.com
Total Funding
$686K
Last Round
$100K GrantDec 2025
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 1 investor for this company. The full record is or through the API.

About

ReNeuroGen LLC is a virtual pharmaceutical company developing systems pharmacology therapies for neurological and pulmonary diseases. Its lead candidate, KYC (N-acetyl-lysyltyrosylcysteine amide), is a tripeptide myeloperoxidase inhibitor being evaluated for Sickle Cell Disease, Multiple Sclerosis, traumatic brain injury, and bronchopulmonary dysplasia. The company is NIH-funded and collaborates with the Medical College of Wisconsin.

Summary

It lists 1–10 employees. It has raised $686K in total across 3 rounds, most recently a $100K Grant round in Dec 2025. Investors include National Institutes of Health.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
GrantDec 2025
$100K

Sign up to see all 3 events

Funding: Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ReNeuroGen LLC on Indexed.vc
<a href="https://indexed.vc/companies/reneurogen-llc"><img src="https://indexed.vc/api/badge/company/reneurogen-llc" alt="ReNeuroGen LLC on Indexed.vc" width="260" height="76" /></a>